Drug Manufacturers - Specialty & Generic · Healthcare
CEO
Equibles does not estimate personal net worth.
Earlier roles on record: CEO at Lifecore Biomedical, Inc. De (LFCR) until May 20, 2024. Lifecore Biomedical, Inc. De reported in an 8-K filed March 21, 2024 that Jim Hall retired as President and Chief Executive Officer, effective May 20, 2024. Lifecore Biomedical, Inc. De reported in an 8-K filed March 21, 2024 that Jim Hall retired as director of the Board, effective May 20, 2024. Jim Hall has spoken on 1 earnings call across 1 company, most recently for Lifecore Biomedical, Inc. De on March 16, 2023. The companies whose calls Jim Hall spoke on are classified in the Healthcare sector.
“This transition follows Jim Hall's announcement of his intent to retire as the Company's President and Chief Executive Officer and as a director of the Board effective upon Mr. Josephs' commencement.”
“This transition follows Jim Hall's announcement of his intent to retire as the Company's President and Chief Executive Officer and as a director of the Board effective upon Mr. Josephs' commencement.”
“And thank you for joining us for our fiscal third quarter update. As announced last week, we took a meaningful step forward with the execution of an enhanced supply agreement with our significant and long-term customer Alcon as well as completing a comprehensive restructuring of our debt arrangements also with Alcon.”
Start not stated–2024-05-20
Drug Manufacturers - Specialty & Generic · Healthcare
CEO